Fund

Ivy Capital

常春藤资本

elsewhere's corpus does not cover Ivy Capital as a subject in its own right. The only mentions found are passing references where Ivy Capital (常春藤资本) appears as a co-investor in two deals: a 2023 Series A in MKSemi led by China Merchants Capital , and a 2020 funding round for Taimei Medical Technology alongside Morningside and others . No entity card, profile, or dedicated coverage of the fund itself is present in the retrieved material.

AI-generated — may contain errors, please verify.

Ivy CapitalFund
常春藤资本
渲染中…
Mentioned in 4 articles

Coverage